These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 25723861)

  • 1. [Extended Pathohistological Criteria for Assessment of the Long-Term Prognosis of Gastric Cancer].
    Dittmar Y; Rauchfuss F; Dondorf F; Ardelt M; Scheuerlein H; Settmacher U
    Zentralbl Chir; 2016 Aug; 141(4):433-41. PubMed ID: 25723861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for survival and recurrence rate in patients with node-negative gastric cancer--a European single-centre experience.
    Dittmar Y; Schüle S; Koch A; Rauchfuss F; Scheuerlein H; Settmacher U
    Langenbecks Arch Surg; 2015 Jan; 400(1):27-35. PubMed ID: 25048355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
    Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
    Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
    Wei J; Yao T; Wang Y; Li L; Pan C; Zhang N
    Clin Transl Oncol; 2019 Feb; 21(2):232-238. PubMed ID: 29968135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of an R1 resection in gastric cancer patients treated with adjuvant chemoradiotherapy.
    Stiekema J; Trip AK; Jansen EP; Boot H; Cats A; Ponz OB; Verheij M; van Sandick JW
    Ann Surg Oncol; 2014 Apr; 21(4):1107-14. PubMed ID: 24306660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reliable risk score for stage IV esophagogastric cancer.
    Blank S; Lordick F; Dobritz M; Grenacher L; Burian M; Langer R; Roth W; Schaible A; Becker K; Bläker H; Sisic L; Stange A; Compani P; Schulze-Bergkamen H; Jäger D; Büchler M; Siewert JR; Ott K
    Eur J Surg Oncol; 2013 Aug; 39(8):823-30. PubMed ID: 23375470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer.
    Abbas SM; Booth MW
    Langenbecks Arch Surg; 2005 Aug; 390(4):294-9. PubMed ID: 15654641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiotherapy in non-cardia gastric cancer patients--does it improve survival?
    Saedi HS; Mansour-Ghanaei F; Joukar F; Shafaghi A; Shahidsales S; Atrkar-Roushan Z
    Asian Pac J Cancer Prev; 2014; 15(20):8667-71. PubMed ID: 25374187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery combined with chemotherapy for recurrent gastric cancer achieves better long-term prognosis.
    Kong F; Qi Y; Liu H; Gao F; Yang P; Li Y; Jia Y
    Clin Transl Oncol; 2015 Nov; 17(11):917-24. PubMed ID: 26088414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer.
    Yu CC; Levison DA; Dunn JA; Ward LC; Demonakou M; Allum WH; Hallisey MT
    Br J Cancer; 1995 May; 71(5):1106-10. PubMed ID: 7734309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
    Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
    Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
    Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in the surgical treatment of gastric cancer--10 years experience.
    Káposztás Z; Kalmár K; Cseke L; Illényi L; Kelemen D; Horváth OP
    Magy Seb; 2007 Apr; 60(2):71-8. PubMed ID: 17649847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
    Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
    Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with early recurrence after curative surgery for gastric cancer.
    Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT
    World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts in gastric cancer surgery.
    Schumacher IK; Hunsicker A; Youssef PS; Lorenz D
    Saudi Med J; 2002 Jan; 23(1):62-8. PubMed ID: 11938366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
    Kim Y; Squires MH; Poultsides GA; Fields RC; Weber SM; Votanopoulos KI; Kooby DA; Worhunsky DJ; Jin LX; Hawkins WG; Acher AW; Cho CS; Saunders N; Levine EA; Schmidt CR; Maithel SK; Pawlik TM
    Surgery; 2017 Aug; 162(2):285-294. PubMed ID: 28578142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.